ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Investigating the Microbiota-Gut-Brain Axis Mechanisms of Transcutaneous Auricular Vagus Nerve Stimulation in Patients with Obesity: A Study Protocol for a Randomized Controlled Trial.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcutaneous auricular vagus nerve stimulation: mechanisms, applications, and research progress.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is a common metabolic disorder affecting nearly one-third of the global population. Emerging evidence indicates that the microbiota-gut-brain axis plays a key role in the pathogenesis of obesity. Transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive neuromodulation technique, may modulate brain function and gut microbiota via vagal pathways. This study aims to evaluate the short-term efficacy of taVNS in reducing body weight in patients with obesity and to explore its underlying mechanisms by assessing changes in neural activity and gut microbial composition. Methods: This single-center, randomized controlled trial will enroll 74 patients with obesity, who will be randomized in a 1:1 ratio to receive either taVNS (electrical stimulation delivered to the left cymba conchae) or sham taVNS (stimulation at the tail of the helix). The primary outcome will be the percentage change in body weight from baseline to Week 12. Secondary outcomes will include anthropometric measures such as changes in body mass index (BMI), waist circumference, hip circumference, body fat percentage, and visceral fat area. Clinical evaluations will be conducted using validated instruments, including the Impact of Weight on Quality of Life-Lite (IWQOL-Lite), Perceived Stress Scale (PSS), Hamilton Depression Rating Scale (HAMD), Dutch Eating Behavior Questionnaire (DEBQ), International Physical Activity Questionnaire (IPAQ), and the Fatigue Scale-14 (FS-14). To investigate modulation of the microbiota-gut-brain (MGB) axis, assessments will include serum brain-gut peptides, gut microbiota composition, and functional magnetic resonance imaging (fMRI). Adverse events will also be systematically monitored throughout the study period. Discussion: This study will preliminarily validate the clinical efficacy of taVNS for obesity. And by integrating measures such as gut peptides, microbiota profiling, and brain imaging, it seeks to link therapeutic effects with microbiota-gut-brain axis modulation. The findings may support taVNS as a safe, non-pharmacological approach for obesity management and inform future neuromodulation-based strategies. Trial Registration Number: ITMCTR2024000518. http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=d4ae9741-2788-433a-9242-a5fe78929bce.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.